Compound Detail

CHEMBL4102267

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

COc1cc(OC)c2c(=O)c3cc(Cl)ccc3oc2c1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4102267
Phase	Preclinical
Structure Type	MOL
InChI Key	PTELSNCFCPIJTF-UHFFFAOYSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

290.7

MW (Da)

3.62

ALogP

HBA

HBD

48.7

PSA (Å²)

0.68

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 5 meas. best 4.94

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
MDA-MB-231 CHEMBL400	IC50	4.94	4.94	11400.0	1
COLO 320 CHEMBL614257	IC50	4.94	4.94	11500.0	1
K562 CHEMBL385	IC50	4.71	4.71	19400.0	1
MCF7 CHEMBL387	IC50	4.67	4.67	21400.0	1
HepG2 CHEMBL395	IC50	4.51	4.51	31200.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
MDA-MB-231	IC50	=	11400.0	nM	4.94	Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by CCK8 a...	28376372
COLO 320	IC50	=	11500.0	nM	4.94	Antiproliferative activity against human COLO320 cells after 48 hrs by CCK8 assa...	28376372
K562	IC50	=	19400.0	nM	4.71	Antiproliferative activity against human K562 cells after 48 hrs by CCK8 assay	28376372
MCF7	IC50	=	21400.0	nM	4.67	Antiproliferative activity against human MCF7 cells after 48 hrs by CCK8 assay	28376372
HepG2	IC50	=	31200.0	nM	4.51	Antiproliferative activity against human HepG2 cells after 48 hrs by CCK8 assay	28376372

PubMed	DOI	Target Context	# Activities
28376372	10.1016/j.ejmech.2017.03.068	MDA-MB-231	1
28376372	10.1016/j.ejmech.2017.03.068	MCF7	1
28376372	10.1016/j.ejmech.2017.03.068	HepG2	1
28376372	10.1016/j.ejmech.2017.03.068	K562	1
28376372	10.1016/j.ejmech.2017.03.068	COLO 320	1

Data from ChEMBL 36 via Core Engine